Evaluation of clinico-pathological criteria and the Ki67 index as prognostic indicators in canine insulinoma

Veterinary Journal

Volumn 185, Issue 1, 2010, Pages 62-67

  Buishand, Floryne O ^a   Kik, Marja ^b   Kirpensteijn, Jolle ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Beta cell tumour; Biomarkers; Dog; Immunohistochemistry; Insulin; Pancreas

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN;

ANIMAL TISSUE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE FREE INTERVAL; DOG DISEASE; FEMALE; FIBROSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INSULINOMA; LYMPH NODE METASTASIS; MALE; NONHUMAN; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; SURVIVAL TIME; TUMOR VOLUME;

ANIMALS; ANTIGENS, NEOPLASM; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; INSULINOMA; KI-67 ANTIGEN; MALE; PANCREATIC NEOPLASMS; PROGNOSIS;

CANIS FAMILIARIS;

EID: 77953673328     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.04.015     Document Type: Article

References (24)

1. Ali A., Serra S., Asa S.L., Chetty R. The predictive value of CK19 and CD99 in pancreatic endocrine tumors. American Journal of Surgical Pathology 2006, 30:1588-1594.
2. Buishand, F.O., Kirpensteijn, J., 2008. LigaSure pancreatectomy in canine insulinomas. In: Scientific Proceedings of the 41st European Veterinary Conference, Voorjaarsdagen, Amsterdam, The Netherlands, p. 244.
3. Capen C.C., Martin S.L. Hyperinsulinism in dogs with neoplasia of the pancreatic islets: a clinical, pathologic, and ultrastructural study. Veterinary Pathology 1969, 6:309-341.
4. Caywood D.D., Klausner J.S., O'Leary T.P., Withrow S.J., Richardson R.C., Harvey H.J., Norris A.M., Henderson R.A., Johnston S.D. Pancreatic insulin-secreting neoplasms: clinical, diagnostic, and prognostic features in 73 dogs. Journal of the American Animal Hospital Association 1988, 24:577-584.
5. Hochwald S.N., Zee S., Conlon K.C., Colleoni R., Louie O., Brennan M.F., Klimstra D.S. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. Journal of Clinical Oncology 2002, 20:2633-2642.
6. Kiupel M., Mueller P.B., Ramos Vara J., Irizarry A., Lin T.L. Multiple endocrine neoplasia in a dog. Journal of Comparative Pathology 2000, 123:210-217.
7. Kruth S.A., Feldman E.C., Kennedy P.C. Insulin-secreting islet cell tumors: establishing a diagnosis and the clinical course for 25 dogs. Journal of the American Veterinary Medical Association 1982, 181:54-58.
8. Kuroda N., Toi M., Nakayama H., Miyazaki E., Yamamoto M., Hayashi Y., Hiroi M., Enzan H. The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions. Histology and Histopathology 2004, 19:59-67.
9. La Rosa S., Rigoli E., Uccella S., Novario R., Capella C. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours. Histopathology 2007, 50:597-606.
10. La Rosa S., Klersy C., Uccella S., Dainese L., Albarello L., Sonzogni A., Doglioni C., Capella C., Solcia E. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Human Pathology 2009, 40:30-40.
11. Leifer C.E., Peterson M.E., Matus R.E. Insulin-secreting tumors: diagnosis and medical and surgical treatment in 55 dogs. Journal of the American Veterinary Medical Association 1986, 188:60-64.
12. Madarame H., Kayanuma H., Shida T., Tsuchiya R. Retrospective study of canine insulinomas: eight cases (2005-2008). The Journal of Veterinary Medical Science 2009, 71:905-911.
13. Mehlhaff C.J., Peterson M.E., Patnaik A.K., Carrillo J.M. Insulin-producing islet cell neoplasms: surgical considerations and general management in 35 dogs. Journal of the American Animal Hospital Association 1985, 21:607-612.
14. Minkus G., Jütting U., Aubele M., Rodenacker K., Gais P., Breuer W., Hermans W. Canine neuroendocrine tumors of the pancreas: a study using image analysis techniques for the discrimination of metastatic versus non-metastatic tumors. Veterinary Pathology 1997, 34:138-145.
15. Minn A.J., Gupta G.P., Padua D., Bos P., Nguyen D.X., Nuyten D., Kreike B., Zhang Y., Wang Y., Ishwaran H., Foekens J.A., Van de Vijver M., Massagué J. Lung metastasis genes couple breast tumor size and metastatic spread. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:6740-6745.
16. Myers N.C., Andrews G.A., Chard-Bergstrom C. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats. American Journal of Veterinary Research 1997, 58:615-620.
17. Pelosi G., Bresaola E., Bogina G., Pasini F., Rodella S., Castelli P., Iacono C., Serio G., Zamboni G. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Human Pathology 1996, 27:1124-1134.
18. Piani C., Franchi G.M., Cappelletti C., Scavini M., Albarello L., Zerbi A., Arcidiacono P.G., Bosi E., Manzoni M.F. Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading. Endocrine-Related Cancer 2008, 15:175-181.
19. Polton G.A., White R.N., Brearley M.J., Eastwood J.M. Improved survival in a retrospective cohort of 28 dogs with insulinoma. Journal of Small Animal Practice 2007, 48:151-156.
20. Rindi G., Klöppel G., Alhman H., Caplin M., Couvelard A., De Herder W.W., Erikssson B., Falchetti A., Falconi M., Komminoth P., Körner M., Lopes J.M., McNicol A.M., Nilsson O., Perren A., Scarpa A., Scoazec J.Y., Wiedenmann B. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 2006, 449:393-401. all other Frascati Consensus Conference participants.
21. Schmitt A.M., Anlauf M., Rousson V., Schmid S., Kofler A., Riniker F., Bauersfeld J., Barghorn A., Probst-Hensch N.M., Moch H., Heitz P.U., Kloeppel G., Komminoth P., Perren A. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. American Journal of Surgical Pathology 2007, 31:1677-1682.
22. Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. Journal of Cellular Physiology 2000, 182:311-322.
23. Tobin R.L., Nelson R.W., Lucroy M.D., Wooldridge J.D., Feldman E.C. Outcome of surgical versus medical treatment of dogs with beta cell neoplasia: 39 cases (1990-1997). Journal of the American Veterinary Medical Association 1999, 215:226-230.
24. Tryfonidou M.A., Kirpensteijn J., Robben J.H. A retrospective evaluation of 51 dogs with insulinoma. The Veterinary Quarterly 1998, 20:114-115.